Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Getting a prescriber's take on Coherus' Cimerli and where biosimilars fit into the wet-AMD treatment landscape

Ticker(s): CHRS, RHHBY

Who's the expert?

Institution: Tyler Retinal Consultants

Vitreoretinal Surgeon and Director of Clinical Research at Tyler Retinal Consultants
Manages 20 patients a week with wAMD
Previous investigator on the SOL clinical trials for Axpaxli; clinical focus on the medical and surgical treatment of diseases affecting the retina, vitreous and macula

Interview Goal

This interview will focus on discussing the treatment landscape of wet age-related macular degeneration (wAMD) and the current approved biosimilar therapies like Coherus' Cimerli

Are You Interested In These Questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.